hashimoto's and glp 1 medication Can a patient with thyroiditis safely be treated with a GLP‑1 receptor agonist (e.g., liraglutide, semaglutide, dulaglutide)? GLP-1 + Thyroid Medication: Safety

It is for informational purposes only and does not replace medical care and advice from a healthcare provider

Safety standards include: Verified sterile preparation areas CE-marked syringes and pharmaceutical-grade vials Clinical record keeping and follow-up scheduling Adherence to Save Face and GHP accreditations No IV drips or unregulated compounds are used only licensed B12 formulations appropriate for intramuscular use

Because metabolic syndrome itself contributes to biliary disease, improved glycemic control may ultimately reduce long-term hepatobiliary risk despite short-term fluctuations

The team highlights a patent-pending peptide and yeast delivery platform, cGMP manufacturing, and third-party testing for identity, purity, and potency

10.1080/21688370.2023.2292461 46 RichardJ